Coagulation inhibitors in alcoholic liver cirrhosis

In the present study we have analyzed the relationship between coagulation inhibitors (antithrombin III, protein C and S, thrombomodulin), liver function impairment, and plasma activity of the endothelium-derived proteins plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI-1) in 27...

Full description

Saved in:
Bibliographic Details
Published inAlcohol (Fayetteville, N.Y.) Vol. 15; no. 1; pp. 19 - 23
Main Authors Raya-Sánchez, J.M., González-Reimers, E., Rodríguez-Martín, J.M., Santolaria-Fernández, F., Molina-Pérez, M., Rodríguez-Moreno, F., Martínez-Riera, A.
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 1998
Elsevier Science
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In the present study we have analyzed the relationship between coagulation inhibitors (antithrombin III, protein C and S, thrombomodulin), liver function impairment, and plasma activity of the endothelium-derived proteins plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI-1) in 27 alcoholic cirrhotic patients and 25 controls. Cirrhotics showed decreased values of all the mentioned parameters except for thrombomodulin, PAI-1, and t-PA. Thrombomodulin and t-PA levels were higher in cirrhotics. No relationship was observed between thrombomodulin and t-PA or PAI-1. Protein C and antithrombin III levels were significantly lower in Child's C patients, whereas no correlation was found between t-PA and thrombomodulin and hepatic function derangement. PAI-1 activity was normal in our patients.
ISSN:0741-8329
1873-6823
DOI:10.1016/S0741-8329(97)00082-7